LIST:
    I am very active in the vaccine issue mostly military with the anthrax 
vaccine. Please see the posts I have sent to many people. Please inform 
others. Now that we are preparing for war, we are getting alot of 
considerations for refusal! Its amazing and I stand with them 100%.
    Here is what I have sent. Please note the CDC website for pictures of 
vaccinated kids reactions. The site worked as of last week so if it doesn't 
now than GO FIGURE!
Jane 
~ ~ ~ ~ ~ ~ ~
Please send this to at least 7 people on your mailing list.

KNOW THE FACTS BEFORE YOU DO THE SURVEY, a picture is worth
a thousand words, these kids were vaccinated!

http://www.bt.cdc.gov/Agent/Smallpox/VaccineImages2.asp

SOURCE: http://www.philly.com/mld/philly/news/nation/4416863.htm

Posted on Fri, Nov. 01, 2002
Caution on child smallpox tests
The FDA wants to give the public a say before it approves trials of a vaccine 
that poses some risk.
By Lauran Neergaard
Associated Press

WASHINGTON - Researchers want to begin the first studies of the effects of a 
smallpox vaccine on toddlers and preschoolers - a proposal raising such 
thorny questions about safety and ethics that the government is seeking 
public reaction before giving the approval.
    Among the issues: The vaccine is made of a live virus called vaccinia 
that can cause its own infections until the injection site scabs over, so 
researchers plan to keep inoculated children out of day care or school for a 
month. But will youngsters tear off their bandages and put relatives, 
playmates or others at risk?
    And is it ethical to test in healthy children a vaccine that could cause 
a life-threatening reaction when they probably will not benefit from the 
vaccine - unless a bioterrorist attacks with smallpox?
    After research oversight boards had mixed reactions, the Food and Drug 
Administration announced yesterday that for the next month it will accept 
public comment on whether the University of California, Los Angeles, and 
Cincinnati Children's Hospital should inoculate 40 2- to 5-year-olds with 
smallpox vaccine.
    "It is a very challenging issue because there is no smallpox circulating 
right now," said Dr. Karen Midthun, the FDA's head of vaccine research. 
"There is great concern that there be a lot of safeguards for studies being 
conducted in children."
    Although smallpox was eradicated in the 1970s, officials fear that 
laboratory samples might have fallen into terrorists' hands. Faced with that 
uncertainty, the Bush administration is preparing to make a vaccine again 
available, first to certain health-care workers and later to the general 
public.
    It is a difficult decision because of the vaccine's risks: Based on 
studies from the 1960s, 15 of every 1 million people vaccinated will suffer 
life-threatening reactions, and one or two of them will die.
    A vaccinated person can spread the vaccine's virus by touching the 
injection site, then touching their eyes or mouth, or someone else. If the 
virus spread to the eye, for instance, it could cause blindness. Someone with 
a weak immune system, such as an AIDS patient, could be killed.
    Children once routinely got the smallpox shot, so why is new testing an 
issue?
The vaccine has been kept frozen for 30 years. To ensure there are enough 
potent shots to go around until new ones are made, scientists are studying 
whether diluted doses work. Recent studies in adults suggested they do. The 
planned pediatric study, sponsored by the National Institutes of Health, 
would test those weaker doses in young children, whose immune systems work 
differently than adults' do.
 ~ ~ ~ ~ ~ ~ ~ ~ ~

Feds seek public input on vaccine

2002-11-01

By Lauran Neergaard

AP Medical Writer



WASHINGTON - The government is seeking public input before it decides whether 
to let a few dozen toddlers and preschoolers be vaccinated against smallpox, 
a study to test the best children's vaccine dose but one raising thorny 
questions about safety and ethics. 

The vaccine is made of a live virus called vaccinia that can cause its own 
infections until the injection site scabs over, so researchers plan to keep 
inoculated children out of day care or school for a month. But still there is 
a chance that youngsters could tear off their bandages and put relatives, 
playmates or others at risk. 


There also is the question of whether it is ethical to test in healthy 
children a vaccine that could cause a life-threatening reaction when the 
children probably won't benefit from it - unless a bioterrorist attacks with 
smallpox. 


After research oversight boards reached mixed conclusions on these issues, 
the Food and Drug Administration announced Thursday that for the next month 
it will accept public comment on whether the University of California, Los 
Angeles, and Cincinnati Children's Hospital should inoculate 40 2- to 
5-year-olds with smallpox vaccine. They would be the first children to get 
the shots since routine vaccination ended in 1972. 


It's highly unusual for the FDA to seek public opinion on research. 


``It is a very challenging issue because there is no smallpox circulating 
right now,'' said Dr. Karen Midthun, the FDA's head of vaccine research. 
``There is great concern that there be a lot of safeguards for studies being 
conducted in children.'' 


``This is an unusual time, it's an unusual need and I think the risks are not 
totally insignificant,'' said Dr. Joel Ward of UCLA, the lead researcher. 
``So I think this extra care is appropriate.'' 


Although wild smallpox was eradicated in the 1970s, officials fear that 
laboratory samples might have fallen into terrorists' hands. Faced with that 
uncertainty, the Bush administration is preparing to make vaccine available 
again, first to certain health care workers and later to the general public. 


It's a difficult decision because of the vaccine's risks. Based on studies 
from the 1960s, 15 of every 1 million people vaccinated will suffer 
life-threatening reactions, and one or two of them will die. 


A vaccinated person can spread the vaccine's virus by touching the injection 
site, then touching the eyes, mouth or someone else. If the virus spread to 
the eye, for instance, it could cause blindness. Someone with a weak immune 
system, such as an AIDS patient, could be killed. 


Children once routinely got the smallpox shot, so why is new testing an 
issue? 


The vaccine has been kept frozen for 30 years. To ensure there are enough 
still-potent shots to go around until new ones are made, scientists are 
studying whether diluted doses work. Recent studies in adults suggest they 
do. The planned pediatric study, sponsored by the National Institutes of 
Health, would test those weaker doses in young children, whose immune systems 
work differently than adults. 


``I would certainly want these trials to be conducted before I would want my 
child to be vaccinated,'' said Dr. Julia McMillan of Johns Hopkins 
University, a spokeswoman for the American Academy of Pediatrics. The academy 
has urged the government since last spring to do child studies before 
allowing broad access to the vaccine. 


It's not just for the child's benefit, she said. The last time children were 
inoculated, their relatives and playmates were too, so no one knows how kids 
might spread vaccinia through today's unvaccinated population. 


Federal regulations require special oversight for research that poses more 
than a minimal risk to a child who won't get a significant benefit. Oversight 
panels and independent experts consulted by the government have said that is 
the case here, because children's risk of getting smallpox is so small. 


Still, most of those experts said the research should be allowed because it 
could benefit society. They did suggest changes, such as limiting 
inoculations to the children of people enrolled in adult smallpox vaccine 
studies, because those parents may better understand the risks. Fully 
explaining the risks to parents is crucial, many said. 


``Many parents incorrectly believe that the risk of potential exposure (to 
smallpox) is very high,'' Johns Hopkins professor Dr. Neal Halsey wrote the 
FDA. 


Under current study plans, no child would be inoculated if the child or a 
family member has immune problems or skin diseases such as eczema that raise 
the risk of vaccine complications. Children who live with a pregnant woman or 
infant would also be ineligible, because babies under age 1 are at 
significantly higher risk of a vaccine-caused brain infection. 


Inoculation sites would be covered with a special bandage that in adult 
studies proved very effective at preventing spread of the vaccine's virus. 
While children are known to rip off bandages, Midthun said this one is extra s
ticky, ``very, very hard to get off.'' 
 


--
The silver-list is a moderated forum for discussion of colloidal silver.

Instructions for unsubscribing may be found at: http://silverlist.org

To post, address your message to: [email protected]

Silver-list archive: http://escribe.com/health/thesilverlist/index.html

List maintainer: Mike Devour <[email protected]>